For: | Gigi E, Lagopoulos VI, Bekiari E. Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review. World J Hepatol 2018; 10(9): 595-602 [PMID: 30310537 DOI: 10.4254/wjh.v10.i9.595] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i9/595.htm |
Number | Citing Articles |
1 |
Po-Yuan Ke. The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions. International Journal of Molecular Sciences 2018; 19(12): 3940 doi: 10.3390/ijms19123940
|
2 |
UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 2019; 7(S8): 189 doi: 10.1177/2050640619854671
|
3 |
Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro Campanini, Alessandro Maria Berton, Alessia Ciancio, Mario Pirisi. Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?. Viruses 2024; 16(12): 1899 doi: 10.3390/v16121899
|
4 |
Yusha Xiao, Baiyang Chen, Kang Yang, Quanxiong Wang, Pengpeng Liu, Yang Gu, Qiu Zhong, Zhisu Liu, Yueming He, Quanyan Liu. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma. Experimental Cell Research 2019; 383(2): 111542 doi: 10.1016/j.yexcr.2019.111542
|
5 |
Sara Kishta, Ashraf Tabll, Tea Omanovic Kolaric, Robert Smolic, Martina Smolic. Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals. Biomedicines 2020; 8(6): 175 doi: 10.3390/biomedicines8060175
|
6 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
|
7 |
Yuki Mori, Shuya Matsuda, Mitsuaki Sato, Masaru Muraoka, Yuichiro Suzuki, Akihisa Tatsumi, Yasuhiro Nakayama, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment. Internal Medicine 2022; 61(18): 2721 doi: 10.2169/internalmedicine.8456-21
|
8 |
Patrick Huber, Robert Thimme. HCV-Therapie und Risiko für hepatozelluläres Karzinom bei Leberzirrhose. Gastro-News 2019; 6(6): 10 doi: 10.1007/s15036-019-0679-0
|
9 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
|
10 |
Dong Lin, Venu Reddy, Hanadi Osman, Adriana Lopez, Ali Riza Koksal, Sadeq Mutlab Rhadhi, Srikanta Dash, Yucel Aydin. Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. Cells 2021; 10(4): 790 doi: 10.3390/cells10040790
|
11 |
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World Journal of Gastroenterology 2022; 28(1): 140-153 doi: 10.3748/wjg.v28.i1.140
|